Hair Relaxer Cancer Lawsuit
Chemical hair straightening products have been linked in multiple studies to an increased risk of uterine cancer, ovarian cancer, and other hormone-related conditions in women.
Last updated June 1, 2026
•ACTIVE CASES
TOP ESTIMATE
HIGHER RISK OF UTERINE CANCER
STATUTE WINDOW
OVERVIEW
Hair Relaxer Lawsuit Overview
What are hair relaxers?
Hair relaxers are chemical products used to straighten curly or textured hair. Many contain endocrine-disrupting chemicals like phthalates, parabens, and formaldehyde-releasing agents, commonly used over long periods.
The cancer link
A major NIH study found women who frequently used chemical hair straighteners had over 2x higher risk of uterine cancer compared to non-users, with additional links to ovarian cancer and fibroids.
Manufacturer liability
Lawsuits allege companies failed to warn users about long-term health risks and marketed these products toward women of color despite known dangers. Federal cases are now consolidated into multidistrict litigation (MDL).
Who is eligible?
Women who regularly used hair relaxers and were later diagnosed with uterine cancer, ovarian cancer, or related conditions may qualify. Diagnosis should follow consistent product use.
The Complete Hair Relaxer Cancer Lawsuit Guide
FREE PDF • 47 PAGES
The Complete Hair Relaxer Cancer Lawsuit Lawsuit Guide
Everything you need to know about the litigation, written in plain English by legal and medical experts.
LITIGATION PROGRESS
Hair Relaxer Lawsuit Timeline
April 2026
Judge sets bellwether pool; MDL grows to 11,371 plaintiffs nationwide.
March 2026
Plaintiffs seek class certification for monitoring claims; MDL enters expert discovery phase.
February 2026
Hair relaxer litigation enters bellwether phase to test liability, causation, and damages.
January 2026
Judge sets deadlines, orders more discovery, and assigns special master to resolve disputes.
Estimated Payout
Claim Requirements
Product Use
Used chemical hair relaxers or straightening products regularly over a period of time.
Medical diagnosis
Diagnosed with uterine cancer, ovarian cancer, or related reproductive conditions.
Timeline Match
Diagnosis occurred after consistent product use, establishing a potential exposure link.
*Claim outcomes depend on diagnosis, timing, and medical records. Similar cases may be valued differently based on each person’s circumstances.
Find a lab nearby
Locate certified MRI and neurology imaging centers to obtain the diagnostic records needed to support your claim.
What to request : Ask for a contrast-enhanced brain MRI specifically looking for meningioma. Request both the radiologist's report and the imaging CD both are needed for your legal claim.
The process
How it works
From submission to attorney match, every case follows the same four-step review.
Submit your case
Answer a short, confidential questionnaire about your product use and diagnosis.
Initial review
A specialist reviews your submission and checks eligibility.
Case manager call
You may be contacted to discuss medical history and records.
Attorney match
If eligible, your case may be referred to a lawyer handling similar claim.
References
SOURCES
Updated June 1, 2026
U.S. Judicial Panel on Multidistrict Litigation
CM/ECF for JPML (LIVE)
United States District Court Northern District of Illinois
https://www.ilnd.uscourts.gov/mdl-details.aspx?91eSFtoI+ycFmA6482wQKA==
National Institutes of Health
https://pubmed.ncbi.nlm.nih.gov/37821068/
National Cancer Institute
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/hair-dyes-fact-sheet
U.S. Food and Drug Administration
https://www.fda.gov/consumers/free-publications-women/hair-dye-and-hair-relaxers
National Institutes of Health
https://pubmed.ncbi.nlm.nih.gov/39063423/
Free Case Evaluation
Check your eligibility today.
Estimated Range